[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-349665-105":59,"doc-detail-349665-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","psma1-psma5-and-psmb2-serve-as-prognostic-biomarkers-and-are-correlated-with-tumor-infiltrating-leukocytes-in-hcc","PSMA1, PSMA5, and PSMB2 serve as prognostic biomarkers and are correlated with tumor-infiltrating leukocytes in HCC","","Hepatocellular carcinoma (HCC) is a major cause of cancer-related death, and reliable prognostic biomarkers are critical for personalized therapy. This study evaluates proteasome (PSM) subunit alpha 1 (PSMA1), alpha 5 (PSMA5), and beta 2 (PSMB2) using integrated bioinformatics resources including cBioPortal, Human Protein Atlas, Oncomine, STRING, Kaplan–Meier plotter, and additional high-throughput databases. Expression, methylation, and genomic alterations are assessed for associations with tumor-infiltrating leukocytes, cancer stage, immune infiltration, and survival outcomes.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/psma1-psma5-and-psmb2-serve-as-prognostic-biomarkers-and-are-correlated-with-tumor-infiltrating-leukocytes-in-hcc/349665/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/psma1-psma5-and-psmb2-serve-as-prognostic-biomarkers-and-are-correlated-with-tumor-infiltrating-leukocytes-in-hcc/349665.png","ImageObject",300,407,{"name":92,"@type":93},"MrHarris58","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What are PSMA1, PSMA5, and PSMB2 and why are they studied in HCC?","Question",{"text":112,"@type":113},"PSMA1, PSMA5, and PSMB2 are proteasome 20S subunits. They are studied because they are overexpressed in cancers including HCC, but their roles in prognosis and immune context are not fully understood.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does the study investigate these genes in relation to prognosis?",{"text":117,"@type":113},"It uses a comprehensive bioinformatics approach integrating multiple databases and tools to examine gene expression, methylation, and genomic alterations, and then correlates these factors with prognosis and immune cell infiltration.",{"name":119,"@type":110,"acceptedAnswer":120},"What is the study’s key conclusion about these proteasome subunits?",{"text":121,"@type":113},"PSMA1, PSMA5, and PSMB2 are proposed as biomarkers for HCC, with their expression associated with poor prognosis and tumor immune cell infiltration.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},349665,1790195054,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},687212988360,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","RESEARCH ARTICLE     \nPSMA1, PSMA5, and PSMB2 serve as prognostic biomarkers and are correlated with tumor-infiltrating leukocytes in HCC  \nBaitul Islama, Weiye Xua, Zaid Ur Rehmanb, Ru Zenga, Thekra Khushafab, Haiyang Yua and Jufang HuangaaDepartment of Anatomy and Neurobiology, School of Basic Medical Sciences, Central South University, Changsha, China;  \nbMolecular Biology Research Center and Hunan Province Key Laboratory of Basic and Applied Hematology, School of Life Sciences, Central South University, Changsha, China  \nABSTRACT  \nHepatocellular carcinoma (HCC) ranks as the third leading cause of cancer-related death. Proteasome (PSM) is the main intracellular proteolytic system in higher eukaryotic cells. It has been reported to be involved in the tumor’s onset, metabolism, and survival, and it has been recognized as a therapeutic target for many human cancers. The 20S proteasome subunits, specifically proteasome 20S subunit alpha 1 (PSMA1), proteasome 20S subunit alpha 5 (PSMA5), and proteasome 20S subunit beta 2 (PSMB2), are overexpressed in various malignancies, including HCC. Nevertheless, the exact role of these genes in HCC prognosis remains only partially understood. Moreover, a reliable predictive biomarker for HCC is essential for supporting the implementation of personalized therapies. Therefore, this study employed a comprehensive bioinformatics approach, integrating data from cBioPortal, Human Protein Atlas (HPA), Oncomine, STRING Viruses, Kaplan–Meier plotter, and other established high-throughput databases and tools. The current study thoroughly examined the expression levels, methylation, and genomic alterations of PSM and their correlation with tumor-infiltrating leukocytes. PSMA1, PSMA5, and PSMB2 are overexpressed in various cancers, including HCC, and their expression levels are associated with tumor grade and stage. The abundance of these genes is linked to diminished DNA methylation levels and genome alterations. Moreover, there was a significant association between the expression levels of these genes and poor prognosis and immune cell infiltration. In conclusion, this study proposes PSMA1, PSMA5, and PSMB2 as biomarkers for HCC.  \nARTICLE HISTORY  \nReceived 17 March 2026 Revised 14 August 2026 Accepted 26 August 2026  \nKEYWORDS  \nProteasome; biomarkers; prognosis; HCC; cancer  \nIntroduction  \nHepatocellular carcinoma (HCC) is the sixth most common cancer around the globe and the third leading cause of cancer-related mortality [ 1] . Various risk factors contribute to the initiation of HCC, with approximately 80% of cases associated with viral infections [2] . Chronic infections by Hepatitis B virus (HBV) and Hepatitis C virus (HCV), play a significant role in HCC pathogenesis [3] . Notably, HCV is responsible for 21% of virus-associated HCC cases [4] . However, the intricate mechanisms underlying this association are complex and not fully elucidated [5] . HCV, in particular, has garnered attention for its significant role in liver diseases, with an estimated 1.7 million new infections annually and a staggering 71 million individuals afflicted globally [6]. Left untreated, HCV can establish viral persistence, leading to liver cirrhosis in approximately 20% of patients, with a subsequent annual HCC incidence of 1–4%[7] . While direct antiviral agents (DAAs) show promise in eradicating HCV, the risk of HCC development inpatients with advanced liver disease remains a concern. Recent reports indicate an unexpected increase in HCC incidence post-DAA treatment, underscoring the incomplete understanding of HCV’s oncogenic mechanisms and the persistence of cancer risk even after viral clearance. Despite advancements, conventional diagnostic methods often fall short in predicting or detecting HCC at an early stage. Thus, identifying biomarkers specific to HCC holds promise to enable timely prediction and early detection, thereby guiding targeted therapeutic interventions.  \nCONTACT Baitul Islam [bait702shr@g","cbCaihEoDYHHoEqr","https://ap.wps.com/l/cbCaihEoDYHHoEqr","pdf",12552014,23,"English","# Abstract\n# Introduction\n# Article history\n# Keywords\n# Contact\n# Supplemental information","[{\"question\":\"What are PSMA1, PSMA5, and PSMB2 and why are they studied in HCC?\",\"answer\":\"PSMA1, PSMA5, and PSMB2 are proteasome 20S subunits. They are studied because they are overexpressed in cancers including HCC, but their roles in prognosis and immune context are not fully understood.\"},{\"question\":\"How does the study investigate these genes in relation to prognosis?\",\"answer\":\"It uses a comprehensive bioinformatics approach integrating multiple databases and tools to examine gene expression, methylation, and genomic alterations, and then correlates these factors with prognosis and immune cell infiltration.\"},{\"question\":\"What is the study’s key conclusion about these proteasome subunits?\",\"answer\":\"PSMA1, PSMA5, and PSMB2 are proposed as biomarkers for HCC, with their expression associated with poor prognosis and tumor immune cell infiltration.\"}]","PSMA1, PSMA5, and PSMB2 serve as prognostic biomarkers and are correlated with tumor-infiltrating leukocytes in HCC | PDF",1790084900,58,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2c51ea5658ec6906a575ff4a49ece40d.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/627f51b33b1cd608b4caedfaca08c2b9.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3cd5d13bd15132cd9fe8354fb5119240.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1f1c5a567278994114ba5aea6220e203.webp",980,1306]